搜尋結果
RNA Sequencing Critical to Identifying Key Fusions for Oncology Patients
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Illumina: At the Phoenix Convention Center in ...
6G Cybersecurity Will Transform How We Deal With Cyberattacks
ACCESSWIRE· 2 年前As researchers and the industry move towards 6G technology, cybersecurity has been recognized ...
The Alkermes Team Is Motivated by Personal Experience With Serious Mental Illness, Addiction ...
ACCESSWIRE· 1 年前Our employees are the foundation upon which our business is built. Their expertise, ...
Empowering Psoriasis Patients Through Mental Health Support
ACCESSWIRE· 2 年前NORTHAMPTON, MA / ACCESSWIRE / October 24, 2022 / Bristol Myers Squibb Company ...
Moderna and Merck Announce mRNA-4157/V940, an Investigational Personalized mRNA Cancer Vaccine, ...
ACCESSWIRE· 1 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
2021 Employee Ideas That Matter Alumni Busier Than Ever With Community-Oriented Projects
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 3, 2022 / The 2021 Employee Ideas that Matter grant ...
Why Clinical Trial Diversity Is So Important - and What the Healthcare Sector Can Do
ACCESSWIRE· 1 年前Physicians prescribe medication and design treatment and therapy plans for their patients based ...
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and ...
ACCESSWIRE· 2 年前Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) ...
【許偉帆醫師 】晚期肝癌的標靶治療與免疫治療
問8健康新聞網 via Yahoo奇摩新聞· 2 年前之前我們已經提到肝癌肝癌是台灣死亡率排名第三的癌症。 臨床上會遇到不少晚期肝癌(Barcelona clinic liver cancer [BCLC] stage C)的患者,這些患者可能罹患B ...
Lung Cancer Is Personal: Interview With Lee James
ACCESSWIRE· 1 年前NORTHAMPTON, MA / ACCESSWIRE / November 8, 2022 / Bristol Myers Squibb Company non-small cell ...